Skip to main content
Year archive

MESOBLAST LTD — 2026 filings

All 64 regulatory filings released by MESOBLAST LTD (MESO) in 2026, sourced directly from the official regulator.

64 Filings
2026 Period
2026 filings (64)
Filing Released Lang
6-K - MESOBLAST LTD (0001345099) (Filer)
Foreign Filer Report
2026-04-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 591.1KB
Regulatory Filings
2026-04-29 English
6-K - MESOBLAST LTD (0001345099) (Filer)
Foreign Filer Report
2026-04-29 English
Patient Recruitment Target Achieved in CLBP Pivotal Trial 3 pages 265.4KB
Regulatory Filings
2026-04-28 English
6-K - MESOBLAST LTD (0001345099) (Filer)
Foreign Filer Report
2026-04-17 English
Notification regarding unquoted securities - MSB 6 pages 18.7KB
Share Issue/Capital Change
2026-04-15 English
Application for quotation of securities - MSB 7 pages 20.7KB
Share Issue/Capital Change
2026-04-15 English
Notification regarding unquoted securities - MSB 5 pages 16.8KB
Share Issue/Capital Change
2026-04-15 English
Notification of cessation of securities - MSB 4 pages 14.8KB
Share Issue/Capital Change
2026-04-15 English
Appendix 3Y for Gregory George 3 pages 246.5KB
Director's Dealing
2026-04-15 English
6-K - MESOBLAST LTD (0001345099) (Filer)
Foreign Filer Report
2026-04-15 English
Acquires CAR Platform for Precision-Enhanced Cell Products 3 pages 258.7KB
M&A Activity
2026-04-14 English
6-K - MESOBLAST LTD (0001345099) (Filer)
Foreign Filer Report
2026-04-08 English
6-K - MESOBLAST LTD (0001345099) (Filer)
Foreign Filer Report
2026-04-08 English
6-K - MESOBLAST LTD (0001345099) (Filer)
Foreign Filer Report
2026-04-08 English
6-K - MESOBLAST LTD (0001345099) (Filer)
Foreign Filer Report
2026-04-08 English
Cleansing Notice 1 page 232.9KB
Regulatory Filings
2026-04-07 English
Application for quotation of securities - MSB 6 pages 18.4KB
Regulatory Filings
2026-04-07 English
FDA Clears Ryoncil IND for Registration Trial in DMD 3 pages 229.0KB
Regulatory Filings
2026-04-07 English
Mesoblast R&D Day Features Commercial & Blockbuster Programs 2 pages 226.1KB
Regulatory Filings
2026-04-07 English
Mesoblast R&D Day Presentation 85 pages 5.0MB
Regulatory Filings
2026-04-07 English
Ryoncil Net Revenue for the Quarter Increases to US$30.3M 2 pages 223.4KB
Regulatory Filings
2026-04-06 English
Proposed issue of securities - MSB 5 pages 17.2KB
Regulatory Filings
2026-04-06 English
3 - MESOBLAST LTD (0001345099) (Issuer)
Director's Dealing
2026-03-24 English
6-K - MESOBLAST LTD (0001345099) (Filer)
Foreign Filer Report
2026-03-23 English
Notification regarding unquoted securities - MSB 6 pages 19.3KB
Regulatory Filings
2026-03-19 English
Appendix 3Ys - S Itescu, E Rose, G George and L Cobley 10 pages 404.9KB
Regulatory Filings
2026-03-19 English
3 - MESOBLAST LTD (0001345099) (Issuer)
Director's Dealing
2026-03-18 English
3 - MESOBLAST LTD (0001345099) (Issuer)
Director's Dealing
2026-03-18 English
3 - MESOBLAST LTD (0001345099) (Issuer)
Director's Dealing
2026-03-18 English
3 - MESOBLAST LTD (0001345099) (Issuer)
Director's Dealing
2026-03-18 English
Mesoblast to Host R&D Day on April 8, 2026 2 pages 239.0KB
Regulatory Filings
2026-03-17 English
Appointment of Clinical Development and Medical Affairs Head 2 pages 232.0KB
Regulatory Filings
2026-03-11 English
Replacement Appendix 3Y for Gregory George 4 pages 383.7KB
Regulatory Filings
2026-03-11 English
Appendix 3Y for Gregory George 3 pages 388.0KB
Regulatory Filings
2026-03-09 English
Becoming a substantial holder 43 pages 4.8MB
Regulatory Filings
2026-03-09 English
Change in substantial holding 5 pages 97.5KB
Regulatory Filings
2026-03-08 English
Half Year Report and Accounts (including Appendix 4D) 106 pages 1.8MB
Regulatory Filings
2026-02-26 English
Corporate Presentation and Half Year Financial Results 28 pages 2.1MB
Regulatory Filings
2026-02-26 English
Ryoncil Profits Underpinning Substantial Growth Pipeline 7 pages 544.5KB
Regulatory Filings
2026-02-26 English
6-K - MESOBLAST LTD (0001345099) (Filer)
Foreign Filer Report
2026-02-23 English
Mesoblast 2026 Half Year Financial Results Webcast 2 pages 229.3KB
Regulatory Filings
2026-02-19 English
High Survival Rates with Ryoncil in SR-aGvHD EIND Program 2 pages 218.3KB
Regulatory Filings
2026-02-11 English
Becoming a substantial holder 57 pages 2.9MB
Regulatory Filings
2026-02-08 English
6-K Filing
Foreign Filer Report
2026-01-29 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 548.6KB
Regulatory Filings
2026-01-28 English
6-K Filing
Foreign Filer Report
2026-01-28 English
Becoming a substantial holder 55 pages 2.9MB
Regulatory Filings
2026-01-26 English
Ceasing to be a substantial holder 34 pages 1.3MB
Regulatory Filings
2026-01-26 English
Real World Experience with Ryoncil Shows 84% Early Survival 3 pages 225.1KB
Regulatory Filings
2026-01-26 English
FDA Confirms Path to Approval for CLBP 3 pages 229.4KB
Regulatory Filings
2026-01-18 English
6-K Filing
Foreign Filer Report
2026-01-16 English
Notification regarding unquoted securities - MSB 6 pages 18.5KB
Regulatory Filings
2026-01-14 English
Notification of cessation of securities - MSB 4 pages 15.4KB
Regulatory Filings
2026-01-14 English
424B3 Filing
Prospectus
2026-01-14 English
Appendix 3Y for Eric Rose 3 pages 267.2KB
Regulatory Filings
2026-01-12 English
Application for quotation of securities - MSB 7 pages 20.5KB
Regulatory Filings
2026-01-12 English
Notification regarding unquoted securities - MSB 6 pages 18.5KB
Regulatory Filings
2026-01-12 English
Appendix 3Y for Lyn Cobley 2 pages 278.4KB
Regulatory Filings
2026-01-11 English
Ryoncil Sales for the Quarter Increase 60% to US$35.1M 2 pages 228.4KB
Regulatory Filings
2026-01-08 English
Notification of cessation of securities - MSB 4 pages 14.7KB
Regulatory Filings
2026-01-05 English
Appendix 3Y for Gregory George 3 pages 286.6KB
Regulatory Filings
2026-01-05 English
6-K
Foreign Filer Report
2026-01-02 English
Mesoblast Announces Changes to Board of Director Roles 2 pages 194.7KB
Regulatory Filings
2026-01-01 English